On June 17, 2024, Director William Hoffman executed a significant transaction by selling 40,000 shares of Inari Medical Inc (NASDAQ:NARI). The shares were sold at a price of $43.54 each, as detailed in the SEC Filing. Following this transaction, the insider now owns 825,359 shares of the company.
Key Insights The projected fair value for Inari Medical is US$40.36 based on 2 Stage Free Cash Flow to Equity With...
Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.